About Taithera
Taithera is a Healthcare company based in New York (United States) founded in 2016. It operates as a nanomedicine platform for targeted bone drug delivery is developed. It operates in the Healthcare and Technology sectors. Its focus areas include Life Sciences, Orthopedics, Drugs and Diversified. Similar companies include SpringWorks Therapeutics, Horizon Therapeutics, Liquidia, Sirnaomics and Acorda and 4 more; 9 of its 9 listed similar companies have raised funding.
Company details
Taithera was founded in 2016 in New York, United States, within the nanomedicine sector. A peptide-based technology is utilized for precise drug delivery to bones, supporting diagnosis, treatment, and prevention of musculoskeletal conditions. These include osteoporosis, bone cancer, fractures, and rejections of bone allografts or autografts. Operations focus on advancing precision medicine solutions for bone-related disorders.
- Headquarters New York, United States
- SectorsHealthcareTechnology
- Email••••••••
- Phone•••• ••••
- Website taithera.com
- Social LinkedIn X
Similar companies to Taithera
Taithera has 9 listed similar companies in our database, 9 of them funded. They include SpringWorks Therapeutics, Horizon Therapeutics, Liquidia, Sirnaomics and Acorda, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| springworkstx.com | 2017 | New York, United States | $229.6M | 305 | Small molecule therapeutics are developed for cancer and rare diseases. | |
| horizontherapeutics.com | 2008 | Dublin, Ireland | $61.78M | – | Developer of drugs for treating rare and autoimmune diseases | |
| liquidia.com | 2004 | United States | $75.3M | 63 | Engineered particles & films for life and material sciences applications | |
| sirnaomics.com | 2007 | Gaithersburg, United States | $267M | 88 | RNA-based therapeutics for cancer and fibrosis are developed. | |
| acorda.com | 1995 | Ardsley, United States | $66.5M | 109 | Engaged in the development and commercialization of therapies that improve neurological function. | |
| histogenics.com | 2000 | Waltham, United States | $115.72M | 69 | Restorative cell therapies for orthopedic diseases are developed. | |
| nanosyrinx.com | 2018 | Coventry, United Kingdom | $21.63M | 17 | Drug delivery systems to cell interiors are developed via nanosyringes. | |
| ostealtx.com | 2013 | San Clemente, United States | $110.8M | – | Developer of pharmaceuticals for musculoskeletal therapeutics to treat orthopedic infections | |
| genedit.com | 2016 | Berkeley, United States | $93.5M | 34 | Genetic medicines are delivered using polymer nanoparticle platforms. |
Detailed similar companies of Taithera
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Orthopedics
10 companies that operate in the same segment as Taithera (Orthopedics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Prosthetic and orthotic devices are developed for individuals with disabilities. | 1919 | Duderstadt, Lower Saxony, Germany | USD 17 M | USD 1.97 B | – | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Developer of drugs for treating rare and autoimmune diseases | 2008 | Dublin, Ireland | USD 61.78 M | USD 617.41 M | – | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M | – | – | |
Robotic arms are provided for mobility and rehabilitation support. | 2004 | Boston, Massachusetts, United States | USD 17.21 M | USD 40.93 M | 185 | |
AI-powered drug discovery platform for various diseases | 2016 | New York, New York, United States | USD 608 M | – | – | |
Exoskeletons for medical rehabilitation and industrial productivity are provided. | 2005 | United States | USD 24.37 M | USD 71.6 M | 61 | |
Stabilization devices for healthcare are manufactured by the company. | 2005 | New York, New York, United States | USD 142.15 M | – | 43 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Taithera
Taithera was founded in 2016.
Taithera is headquartered in New York, United States. It is registered at New York, New York, United States.
Taithera was founded in 2016 in New York, United States, within the nanomedicine sector. A peptide-based technology is utilized for precise drug delivery to bones, supporting diagnosis, treatment, and prevention of musculoskeletal conditions. These include osteoporosis, bone cancer, fractures, and rejections of bone allografts or autografts. Operations focus on advancing precision medicine solutions for bone-related disorders.
Taithera's top competitors include SpringWorks Therapeutics, Horizon Therapeutics and Sirnaomics.